2822
N. Lin et al. / Tetrahedron: Asymmetry 21 (2010) 2816–2824
Na2SO4 and concentrated under reduced pressure to afford product
1.0 mL/min, UV detection at 208 nm, tminor = 7.67 min, tmajor =
9.05 min, ee 81%.
1128 as an oil (7.23 g, 98% yield) (Scheme 3). 1H NMR (400 MHz,
CDCl3):
d 1.05–1.27 (m, 5H), 1.31–1.43 (m, 2H), 1.54–1.67
(m, 3H), 1.91–2.05 (m, 3H), 2.25 (d, J = 4.2 Hz, 1H), 3.68 (s, 3H),
3.70–3.83 (m, 1H), 3.96–4.07 (m, 2H), 4.16–4.25 (m, 1H).
4.3.2. (+)-Ethyl 3-hydroxy-3-p-tolylbutanoate 6b36
½
a 2D0
ꢃ
¼ þ7:1 (c 0.4, CHCl3). 1H NMR (400 MHz, CDCl3): d 1.14
A solution of methyl ester 11 (3.0 g, 16.4 mmol) in Et2O (10 mL)
was added dropwise to a solution of 3,5-di-CF3-PhMgBr (3 M in
Et2O, 22 mL, 65 mmol) at 0 °C. The resulting mixture was stirred
at 0 °C for 3 h. The reaction was quenched with aqueous saturated
NH4Cl, and the aqueous phase was extracted with Et2O. The com-
bined organic extracts were washed with brine, dried over MgSO4,
and concentrated under reduced pressure. The residue was puri-
fied by column chromatography to afford product 12 as a white
solid (9.8 g, 92% yield). 1H NMR (400 MHz, CDCl3): d 0.74–0.89
(m, 2H), 1.14–1.29 (m, 7H), 1.38–1.67 (m, 3H), 1.84–1.91
(m, 1H), 2.13–2.21 (m, 1H), 3.67–3.74 (m, 1H), 3.97–4.05
(m, 1H), 4.12–4.20 (m, 1H), 4.87 (dd, J = 7.0, 11.0 Hz, 1H), 7.79
(s, 1H), 7.83 (d, J = 6.7 Hz, 3H), 7.89 (s, 2H), 8.22 (s, 1H). 13C NMR
(100 MHz, CDCl3): d 14.37, 20.07, 23.47, 25.38, 27.11, 32.30,
35.29, 59.46, 62.77, 67.81, 80.84, 121.92, 124.50, 127.94, 128.98,
131.01, 131.34, 131.60, 131.93, 144.17, 146.36, 159.38.
KOH (21.12 g, 377 mmol) was added at 0 °C to a solution of 12
(9.8 g, 15.08 mmol) in MeOH (75 mL). The reaction mixture was re-
fluxed overnight. After cooling, the solvent was evaporated under
reduced pressure, 100 mL of H2O was added. The aqueous phase
was extracted with CH2Cl2, washed with brine, dried over MgSO4,
and concentrated under reduced pressure. The residue was puri-
fied by column chromatography to afford pure product L6 as a
(t, J = 7.1 Hz, 3H), 1.52 (s, 3H), 2.32 (s, 3H), 2.77 (d, J = 15.9 Hz,
1H), 2.95 (d, J = 15.9 Hz, 1H), 4.06 (q, J = 7.1 Hz, 2H), 4.33 (s, 1H),
7.13 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz,
CDCl3): d 14.00, 20.93, 30.71, 46.45, 60.67, 72.62, 124.37, 128.91,
136.36, 143.97, 172.72. HPLC conditions: Daicel Chiralcel AS-H
column, hexane/i-PrOH 99:1, flow rate 1.0 mL/min, UV detection
at 214 nm, tminor = 7.55 min, tmajor = 8.72 min, ee 87%.
4.3.3. (+)-Ethyl 3-hydroxy-3-(4-methoxyphenyl)butanoate 6c37
½
a 2D0
ꢃ
¼ þ4:2 (c 0.6, CHCl3). 1H NMR (400 MHz, CDCl3): d 1.15
(t, J = 7.1 Hz, 3H), 1.52 (s, 3H), 2.76 (d, J = 15.8 Hz, 1H), 2.94
(d, J = 15.8 Hz, 1H), 3.79 (s, 3H), 4.06 (q, J = 7.1 Hz, 2H), 4.34
(s, 1H), 6.86 (d, J = 8.9 Hz, 2H), 7.36 (d, J = 8.9 Hz, 2H). 13C NMR
(100 MHz, CDCl3): d 14.01, 30.73, 46.53, 55.22, 60.70, 72.48,
113.52, 125.65, 139.07, 158.40, 172.74. HPLC conditions: Daicel
Chiralcel AS-H column, hexane/i-PrOH 99:1, flow rate 1.0 mL/min,
UV detection at 234 nm, tminor = 17.66 min, tmajor = 21.48 min, ee
81%.
4.3.4. (ꢁ)-Ethyl 3-(2-chlorophenyl)-3-hydroxybutanoate 6d9
½
a 2D0
ꢃ
¼ ꢁ5:6 (c 0.4, CHCl3). 1H NMR (400 MHz, CDCl3): d 1.09
(t, J = 7.1 Hz, 3H), 1.72 (s, 3H), 2.94 (d, J = 16.0 Hz, 1H), 3.57
(d, J = 15.9 Hz, 1H), 4.02 (q, J = 7.1 Hz, 2H), 4.69 (s, 1H), 7.19
(t, J = 7.5 Hz, 1H), 7.30 (m, 2H), 7.86 (dd, J = 1.2, 7.9 Hz, 1H); 13C
white solid (13.7 g, 91% yield). ½a D20
ꢃ
¼ ꢁ50:6 (c 1.0, CHCl3). 1H
NMR (400 MHz, CDCl3): d 1.23–1.36 (m, 3H), 1.46–1.69 (m, 8H),
2.05–2.13 (m, 1H), 3.31 (dd, J = 5.6, 11.3 Hz, 1H), 4.39
(t, J = 8.1 Hz, 1H), 5.24 (s, 1H), 7.76 (d, J = 6.7 Hz, 2H), 7.96
(s, 2H), 8.06 (s, 2H). 13C NMR (100 MHz, CDCl3): d 21.97, 23.35,
28.26, 30.34, 32.08, 36.98, 56.64, 63.91, 75.79, 121.25, 121.50,
121.84, 124.54, 125.57, 126.00, 131.62, 131.91, 131.95, 132.24,
NMR (100 MHz, CDCl3): d 13.91, 27.18, 43.77, 60.71, 73.08,
126.94, 128.02, 128.56, 130.43, 131.16, 142.92, 172.92. HPLC con-
ditions: Daicel Chiralcel AS-H column, hexane/i-PrOH 99:1, flow
rate 1.0 mL/min, UV detection at 214 nm, tminor = 6.78 min, tmajor
=
7.48 min, ee 87%.
146.53, 149.47. HRMS (ESI-TOF): m/z calcd for
C25H20NOF12
4.3.5. (+)-Ethyl 3-(3-chlorophenyl)-3-hydroxybutanoate 6e
[MꢁH]+ 578.1353; found: 578.1354.
½
a 2D0
ꢃ
¼ þ2:9 (c 0.8, CHCl3). 1H NMR (400 MHz, CDCl3): d 1.15
(t, J = 7.1 Hz, 3H), 1.52 (s, 3H), 2.78 (d, J = 16.0 Hz, 1H), 2.94
(d, J = 16.0 Hz, 1H), 4.08 (q, J = 7.1 Hz, 2H), 4.47 (s, 1H), 7.25 (m,
3H), 7.47 (t, J = 1.7 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 13.98,
30.52, 46.14, 60.88, 72.50, 122.73, 125.03, 127.01, 129.54, 134.25,
149.10, 172.48. HRMS (ESI-TOF): m/z calcd for C12H15O3ClNa
[M+Na]+ 265.0607; found: 265.0586. HPLC conditions: Daicel Chi-
ralcel OD-H column, hexane/i-PrOH 99:1, flow rate 0.5 mL/min, UV
detection at 226 nm, tminor = 17.12 min, tmajor = 18.23 min, ee 78%.
4.3. Typical procedure for the Reformatsky reaction of ketones
with ethyl bromoacetate
Under a nitrogen atmosphere, zinc powder (97.5 mg, 1.5 mmol),
NiBr2 (27.3 mg, 0.125 mmol), ligand L5 (41.2 mg, 0.125 mmol), and
anhydrous THF (1 mL) were added to a dried Schlenk flask. Then
the mixture was stirred at 0 °C, after which the ketone (0.5 mmol)
and ethyl bromoacetate (83
flask via syringe. The suspension was stirred for 10 min, and
then CF3COOH (5 L, 0.0625 mmol) was added to activate the zinc
lL, 0.75 mmol) were added to the
4.3.6. (+)-Ethyl 3-(4-chlorophenyl)-3-hydroxybutanoate 6f9
l
½
a 2D0
ꢃ
¼ þ14:8 (c 0.5, CHCl3). 1H NMR (400 MHz, CDCl3): d 1.15
powder. The reaction mixture was stirred at 0 °C for 48 h and
quenched with 1 M hydrochloric acid (8 mL). Then 8 mL of diethyl
ether were added. The aqueous layer was extracted with Et2O
(8 mL ꢂ 2) and the combined organic layers were washed with
saturated brine (4 mL), and dried over Na2SO4. Evaporation of
the solvent and flash chromatography (hexane/ethyl acetate
20:1) gave a colorless oil. The enantiomeric excess was deter-
mined by HPLC with Daicel Chiralcel OD-H, AD-H or AS-H
columns.
(t, J = 7.1 Hz, 3H), 1.52 (s, 3H), 2.77 (d, J = 16.0 Hz, 1H), 2.93
(d, J = 16.0 Hz, 1H), 4.07 (q, J = 7.1 Hz, 2H), 4.43 (s, 1H), 7.30
(d, J = 8.7 Hz, 2H), 7.39 (d, J = 8.7 Hz, 2H). 13C NMR (100 MHz,
CDCl3): d 13.99, 30.62, 46.20, 60.88, 126.04, 128.35, 132.69,
145.47, 172.55. HPLC conditions: Daicel Chiralcel AS-H column,
hexane/i-PrOH 99:1, flow rate 1.0 mL/min, UV detection at
208 nm, tminor = 10.06 min, tmajor = 11.71 min, ee 83%.
4.3.7. (S)-(+)-Ethyl 3-(4-bromophenyl)-3-hydroxybutanoate 6g9
½
a 2D0
ꢃ
¼ þ13:9 (c 0.4, CHCl3). 1H NMR (400 MHz, CDCl3): d 1.15
4.3.1. (S)-(ꢁ)-Ethyl 3-hydroxy-3-phenylbutanoate 6a9
a 2D0
ꢃ
¼ ꢁ12:1 (c 1.7, CHCl3). 1H NMR (400 MHz, CDCl3): d 1.13
(t, J = 7.1 Hz, 3H), 1.51 (s, 3H), 2.77 (d, J = 16.0 Hz, 1H), 2.93
(d, J = 16.0 Hz, 1H), 4.06 (q, J = 7.1 Hz, 2H), 4.43 (s, 1H), 7.33
(d, J = 8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 2H). 13C NMR (100 MHz,
½
(t, J = 7.1 Hz, 3H), 1.54 (s, 3H), 2.79 (d, J = 15.9 Hz, 1H), 2.97
(d, J = 15.9 Hz, 1H), 4.06 (q, J = 7.1 Hz, 2H), 4.37 (s, 1H), 7.23
(dt, J = 4.0, 7.2 Hz, 1H), 7.33 (t, J = 7.3 Hz, 2H), 7.45 (d, J = 7.9 Hz,
2H). 13C NMR (CDCl3, 100 MHz): d 13.98, 30.63, 46.47, 60.71,
72.75, 124.46, 126.84, 128.22, 146.85, 172.68. HPLC conditions:
Daicel Chiralcel AS-H column, hexane/i-PrOH 99:1, flow rate
CDCl3):
d 14.00, 30.56, 46.15, 60.87, 72.50, 120.82, 126.43,
131.29, 146.03, 172.50. HPLC conditions: Daicel Chiralcel OD-H
column, hexane/i-PrOH 95:5, flow rate 1.0 mL/min, UV detection
at 234 nm, tminor = 5.56 min, tmajor = 6.09 min, ee 86%.